Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Melanoma 5Colitis 4Carcinoma, Non-Small-Cell Lung 3Urogenital Neoplasms 2Vasculitis 1Stroke 1Skin Neoplasms 1Lung Neoplasms 1Kidney Transplantation 1Hepatitis 1Hematologic Neoplasms 1Graft vs Host Disease 1Drug-Related Side Effects and Adverse Reactions 1Depressive Disorder, Treatment-Resistant 1Depressive Disorder, Major 1Depression 1Colitis, Ulcerative 1Bronchiolitis Obliterans Syndrome 1Bipolar Disorder 1Aneurysm 1

Interventions

vedolizumab 1Surveys and Questionnaires 1Photopheresis 1Phlebotomy 1Mycophenolic Acid 1Methoxsalen 1Infliximab 1Blood Specimen Collection 1Azathioprine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hepatitis × Infliximab × 1 year × Clear all
NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting
112 enrolled
Dermatologic

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡